Skip to content

Dr. Reddy's Laboratories

US · RDY #1451 by market cap Listed 1970
14.89 +0.06 +0.40%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 9 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.1 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
63.75% +1.12pp
Institutions
399 -9
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund41.97%
Individual/Insider26.72%
Public Company15.54%
Hedge Fund2.49%
Private Company0.96%
Sovereign Wealth Fund0.85%
Government Pension Fund0.78%
Government0.64%
Corporate Pension Plan0.29%
Other9.76%

Top holders as of 2026-03-31

Kallam Reddy 13.61% · 113.38M sh
Gunupati Prasad 13.07% · 108.91M sh
Life Insurance Corporation of India 12.18% · 101.50M sh
ICICI Prudential Asset Management Company Limited 5.05% · 42.05M sh
BlackRock 4.03% · 33.56M sh
Vanguard Capital Management, LLC 3.14% · 26.13M sh
Morgan Stanley Investment Management Inc. 2.92% · 24.29M sh
Morgan Stanley 2.92% · 24.29M sh
Boston Partners Global Investors, Inc. 2.17% · 18.04M sh
PPFAS Asset Management Private Limited 2.91% · 24.23M sh
Nippon Life India Asset Management Limited 1.79% · 14.88M sh
RBC Global Asset Management Inc. 1.88% · 15.68M sh
J.P. Morgan Asset Management, Inc. 1.46% · 12.14M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

9 filings tracked · 0 buys · 1 sells

NameRoleStake
Kallam Reddy Chairman of the Board & Member of the Management Council 13.61%
Gunupati Prasad Co-Chairman, MD & Member of Management Council 13.07%
Deepak Sapra Former CEO – API and Services & Member of Management Council 0.01%
Motupalli Ramana CEO of Global Generics & Member of Management Council 0.01%
Milan Kalawadia CEO of North America & Member of Management Council 0.01%
M S Sundar Global Head of Quality and PV & Member of Management Council 0.00%
Bhethanabottla Phanimitra Chief Digital & Information Officer and Member of the Management Council 0.00%
Sushrut Kulkarni Former Global Head of Integrated Product Development Organisation & Member of the Management Council 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-03-31 M S Sundar Global Head of Quality and PV & Member of Management Council Initial Statement of Beneficial 0 --
2025-12-17 Gunupati Prasad Co-Chairman, MD & Member of Management Council Initial Statement of Beneficial 0 --
2025-12-17 Kallam Reddy Chairman of the Board & Member of the Management Council Initial Statement of Beneficial 0 --
2025-12-17 Deepak Sapra Former CEO – API and Services & Member of Management Council Initial Statement of Beneficial 0 --
2025-12-17 Motupalli Ramana CEO of Global Generics & Member of Management Council Initial Statement of Beneficial 0 --
2025-12-17 Milan Kalawadia CEO of North America & Member of Management Council Initial Statement of Beneficial 0 --
2025-12-17 Sushrut Kulkarni Former Global Head of Integrated Product Development Organisation & Member of the Management Council Initial Statement of Beneficial 0 --
2025-12-17 Bhethanabottla Phanimitra Chief Digital & Information Officer and Member of the Management Council Initial Statement of Beneficial 0 --
2024-07-28 Erez Israeli CEO & Member of the Management Council Intent to Sell (Form 144) -327,500 $16.46
2023-10-29 Erez Israeli CEO & Member of the Management Council Intent to Sell (Form 144) -25,000 $13.09

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Dr. Reddy's Laboratories discussion 0 comments

Add a comment